“…Twenty‐two percent of PGx studies did not include explicit descriptions of ethnic diversity in the study populations, suggesting that both editors and authors need to be more careful in their documentation and review of this important information. A recent special themed issue in March 2023 and a mini‐theme in October 2021 have spotlighted the crucial topic of DEI and gained wide acclaim from our readers, authors, and editors 4,5 . CPT aims to further enhance DEI, adhere to relevant guidelines, and promote research among minority populations to better understand the frequently vast variability in drug response and to ultimately achieve effective and safe use of therapeutics in all patients.…”